| Machine learning, Natural Language Processing |
2023.03 - |
Improving Generalization Performance of Natural Language Processing Models to Extract Drug Safety Information from Multi-institutional Clinical Notes |
Ongoing |
| RWD/RWE, Machine learning |
2022.12 - |
Improved prediction of acute coronary syndrome by replacing binary categorical variables with propensity scores in patients with type 2 diabetes mellitus |
Ongoing |
| Clinical Pharmacology |
2022.12 - |
An analysis of clinical trial designs for COVID-19 therapeutics development in Korea and suggestions for improvement |
Ongoing |
| RWD/RWE |
2022.11 - 2024.03 |
A real-world data-based retrospective observational study to evaluate effectiveness and safety of steroid pretreatment prior to remission induction chemotherapy in patients with pediatric acute lymphoblastic leukemia |
Completed |
| RWD/RWE, Machine learning |
2022.08 - |
Drug repurposing framework based on crossover clinical trials emulated by using electronic health records and Bayesian Additive Regression Tree (BART) |
Ongoing |
| RWD/RWE |
2022.07 - 2024.02 |
Trajectory of clinical features in Korean COVID-19 patients: an observational study based on real-world data |
Completed |
| Clinical Pharmacology, Regulatory Science |
2022.07 - 2024.02 |
Country Contribution of Investigators to Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration |
Completed |
| Machine learning |
2022.07 - 2023.12 |
Comparison of artificial intelligence and pharmacometric models for predicting plasma concentrations of antiepileptic drugs based on therapeutic drug monitoring records |
Completed |
| Machine learning |
2022.05 - 2023.04 |
Joint research with Microsoft Research Asia (MSRA): Revisiting and reformulating machine learning-based drug repositioning using clinical trials database and eligibility criteria information |
Completed |
| RWD/RWE |
2022.04 - |
Development of a registry and generation of real-world evidence using electronic medical record-based real-world data for pediatric acute lymphoblastic leukemia |
Ongoing |
| RWD/RWE |
2021.06 - 2021.08 |
Real-World Data based Patient Journey of Cancer Patients |
Completed |
| RWD/RWE |
2021.05 - 2024.03 |
Dulaglutide in the real world: Common Data Model-based retrospective analysis on adherence and persistence of dulaglutide and its patient characteristics |
Completed |
HOME
